Precision Optics (NASDAQ:POCI) Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Precision Optics (NASDAQ:POCI) issued its quarterly earnings data on Monday. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.05, FiscalAI reports. Precision Optics had a negative net margin of 17.03% and a negative return on equity of 37.47%. The business had revenue of $8.77 million during the quarter, compared to analysts’ expectations of $7.10 million.

Precision Optics Price Performance

Shares of POCI traded down $0.10 during midday trading on Monday, hitting $4.53. The company’s stock had a trading volume of 410,906 shares, compared to its average volume of 38,424. The company has a quick ratio of 1.74, a current ratio of 2.10 and a debt-to-equity ratio of 0.04. Precision Optics has a one year low of $3.55 and a one year high of $6.15. The stock has a market capitalization of $49.56 million, a price-to-earnings ratio of -7.19 and a beta of 0.32. The company’s fifty day simple moving average is $4.36 and its two-hundred day simple moving average is $4.63.

Wall Street Analyst Weigh In

POCI has been the subject of a number of analyst reports. Wall Street Zen upgraded shares of Precision Optics to a “hold” rating in a research report on Saturday, August 15th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Precision Optics in a research report on Wednesday, September 2nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Precision Optics presently has an average rating of “Sell”.

Precision Optics Company Profile

Precision Optics Corporation, Inc (NASDAQ: POCI) designs and manufactures advanced optical and imaging systems, primarily for the medical device market. The company develops products used in minimally invasive surgery, including endoscopes, surgical cameras, and specialized visualization systems that help physicians view internal anatomy during diagnostic and therapeutic procedures.

Its product portfolio includes reusable and single-use endoscopes, three-dimensional imaging systems, fluorescence imaging technologies, and custom optical components and assemblies.